title: Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1].
authors.forename: L
authors.initials: L
authors.lastname: Maffioli
authors.forename: A
authors.initials: A
authors.lastname: Chiti
authors.forename: M
authors.initials: M
authors.lastname: Gasparini
authors.forename: E
authors.initials: E
authors.lastname: Bombardieri
mesh_terms: D001549:Benzamides; D003287:Contrast Media; D018492:Dopamine Antagonists; D006801:Humans; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D008545:Melanoma / Q000000981:diagnostic imaging*; D011759:Pyrrolidines; D016719:Radioimmunodetection; D012680:Sensitivity and Specificity; D012878:Skin Neoplasms / Q000000981:diagnostic imaging*; D013004:Somatostatin / Q000031:analogs & derivatives*
chemical_list: D001549:Benzamides; D003287:Contrast Media; D018492:Dopamine Antagonists; D007205:Indium Radioisotopes; D007457:Iodine Radioisotopes; D011759:Pyrrolidines; D013004:Somatostatin; C055743:3-iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide; C081788:pentetreotide